MedTech I.Q.

The Cutting Edge of Medical Technology Content, Community & Collaboration

All Blog Posts Tagged 'pharma' (11)

PharmAbcine Announces FDA Orphan Drug Designation Granted to TTAC-0001

PharmAbcine Inc., a clinical-stage biotech company developing novel antibody therapeutics for multiple cancer indications, announced today that U.S. Food and Drug Administration (FDA) has granted orphan drug designation to its leading clinical compound TTAC-0001 for “treatment of Glioblastoma Multiforme.”

“We are very pleased with this Orphan Drug Designation from FDA for TTAC-0001 for GBM treatment since we have been preparing for clinical studies of TTAC-0001 plus KEYTRUDA®…


Added by John Robinson on April 2, 2018 at 7:29am — No Comments

All about Microbial Control, Monitoring, Validation and Troubleshooting of Pharmaceutical Water Systems

All about Microbial Control, Monitoring, Validation and Troubleshooting of Pharmaceutical Water Systems


Most pharmaceutical biofilms, especially those in water systems, suffer from one major flaw: misconceptions. Strict and rigid rules for design and operations, especially when they are built on…


Added by John Robinson on September 4, 2017 at 6:34am — No Comments

Effective legal writing skills are essential for FDA submissions


A number of reasons make cultivation of the art of effective legal writing skills for FDA submissions important. Documents that are submitted to the FDA are…


Added by John Robinson on July 31, 2017 at 6:28am — No Comments

FDA and EU requirements on data integrity and implementation


Added by John Robinson on April 17, 2017 at 5:49am — No Comments

Applied Statistics for FDA Process Validation 2017


Added by John Robinson on April 12, 2017 at 5:30am — No Comments

What will business life be like in the future?

I wanted to start this post with a flow diagram that resonated with me so much that I immediately sent it to my Mother. I’ve been doing ‘tech support’ for my family for years, and for Geoff and, and, and. I expect you’ve been doing it too.

But although funny, truthful and nicely wry, the diagram got me thinking about what web 2.0 really means in real life. How does it change some of the things we consider to be ‘normal’ now and… Continue

Added by Rebecca Caroe on August 26, 2009 at 6:48am — No Comments

Migrating Pharma to Web 2.0

I had occasion this week to write the specification for two website redesigns. And that has set me thinking about the new state of affairs within the wide range of marketing communications that includes a website as a communication tool.

When I was taught my trade we had a series of headings in our marketing budget and plan that included the word “Collateral” which used to mean anything-printed-that-promotes-our-brand.

Well, collateral now includes digital stuff as well as print and… Continue

Added by Rebecca Caroe on August 17, 2009 at 3:16am — No Comments

Pharma Brand Launches & Herding Cats

Thinking Pharma is delighted to Welcome it’s new SEVP of Thinking Pharma – Sally Church.

Dr Sally is an eminent Blogger and Marketeer. Sally’s own enterprise, Icarus Consultants, will continue as we complete the transition into Thinking Pharma in the mean time enjoy Sally’s Thoughtware.

“Anyone can herd cattle” is like saying, “Anyone can go through the motions of a… Continue

Added by Rebecca Caroe on August 11, 2009 at 10:13am — No Comments

A visionary for the future of Pharma marketing? Or just slow progress

Jon Richman has done a fine column in Advertising Age about the future of digital marketing for pharma. He is drawn into five major predictions

1. Patients will have a portable network tool showing recommendations from trusted friends

2. Service companies who match patients with similar conditions to each other using opt-ins from electronic medical records

3. Pharma will abandon their own websites… Continue

Added by Rebecca Caroe on August 5, 2009 at 5:08am — No Comments

Thinking Pharma Thoughtware: Pharma Social Media – Trouble in Grandstand

Ever watched two kids splitting hairs about something that they are actually both agreed upon and then mum arrives to sort things out and somewhat misses the point completely?

The principles inherent in a recent blog post interchange between Jonathan Richman, Fard Johnmar… Continue

Added by Rebecca Caroe on July 27, 2009 at 5:48am — 1 Comment

Pfizer & Glaxo Ink Multi-Million Dollar R&D Deals with Academia

Biotech Transfer Week reports that Pfizer and Glaxo Smith Kline (GSK) are continuing the trend toward the pharmaceutical industry funding large partnerships with academic research institutions to invigorate their innovation pipelines. The full Ben Butkus article is an excellent overview of recent initiatives by industry to leverage academic discovery.

Added by CC-Conrad Clyburn-MedForeSight on July 4, 2008 at 2:00pm — No Comments

Monthly Archives













© 2018   Created by CC-Conrad Clyburn-MedForeSight.   Powered by

Badges  |  Report an Issue  |  Terms of Service